SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs admitted affair with a business executive and the Nvidia boards independent investigation have drawn attention, with traders debating whether the unverified espionage allegations and potential leadership fallout pose a serious risk or are an overreaction unrelated to Nvidias AI business. Many are buying the selloff on confidence in the companys fundamentals, while others remain cautious about the investigation and possible CEO succession concerns.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

IBRX is selling off after a weaker-than-expected Q3 report, with traders focused on the revenue decline, slowing commercial uptake and possible future dilution. The reaction is mixed: critics question execution and the cash outlook, while bullish traders argue the positive BCG-naive trial result and Israeli approval support the longer-term Anktiva story.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

A sharp pre-earnings rally ahead of TTDs Q3 report has traders debating whether hopes for a turnaround and possible short covering are driving the move; others remain cautious given concerns about slowing growth and weak guidance.

Clover Health Investments Corp. is a physician enablement technology company, which engages in the provision of Medicare Advantage plans in the United States. Its strategy is powered by its proprietary software platform, Clover Assistant, which aggregates patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic diseases. The company offers PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. The company was founded by Vivek Garipalli and Andrew Toy on July 17, 2014 and is headquartered in Wilmington, DE.

Clover Health Investments Corp - Ordinary Shares - Class A

Clover Health Investments Corp

Clovers Q3 earnings beat and improved full-year outlook, alongside a profitable quarter and strong membership growth, are fueling renewed buying and a push to hold above $5. Traders are divided over whether the gains can stick, with some focused on the companys growth and others disappointed by the lack of concrete Counterpart Health software revenue updates.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Q3 earnings expectations and Hims & Hers Eli Lilly partnership, which brings Zepbound and Foundayo onto its platform, are driving attention. Traders debate whether the added branded-drug business can offset expected margin pressure, while the stocks sharp swings have fueled unverified earnings-leak speculation.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webulls China-related scrutiny, including a congressional report alleging undisclosed ties and subsequent securities lawsuits, is dominating discussion amid a prolonged share-price decline. Traders disagree over whether the concerns are misleading or a genuine overhang; bullish holders cite the companys growth and upcoming earnings, while bearish voices remain focused on the risk of further losses.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics BRIUMVI-driven quarterly beat and raised revenue outlook are drawing attention, but shares have fallen as traders debate a sell-the-news reaction versus a buying opportunity. The upcoming Phase 3 readout for subcutaneous BRIUMVI is widely viewed as the next major catalyst.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Traders are linking ARWRs sharp decline to weak early sales for rival Ioniss Tryngolza, raising concerns about the commercial outlook for Arrowheads Redemplo despite some arguing its data and product profile are stronger. Others point to Arrowheads high cash burn and possible financing needs as added pressure.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Attention centers on Candels planned Q4 2026 FDA BLA submission for CAN-2409 in localized prostate cancer, following positive Phase 3 results and recent immune-profiling and viral-shedding updates. Bulls view the filing as a key catalyst, while skeptics question the timeline and managements transparency and raise concerns about dilution amid the stocks decline.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

Mercks positive Phase 2b hidradenitis suppurativa data has renewed debate about competition for MoonLakes sonelokimab, while bullish traders emphasize that MLTXs program is further advanced and its BLA has been submitted. The upcoming FDA decision on whether to accept the application is a key milestone, but concerns about competition and MoonLakes ability to commercialize independently temper optimism.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$UPLD Growth and profitability projected for 2027. Cash on hand as of the end of the third quarter of 2026 was $28.9 million, and the company&#39;s $30.0 million revolving credit facility remained undrawn.

Bulldogs79

Benfica37

StockTwits Web

Upland Software Inc

 Growth and profitability projected for 2027. Cash on hand as of the end of the third quarter of 2026 was $28.9 million, and the company's $30.0 million revolving credit facility remained undrawn.